dc.contributor.author | WAHYUDI, Septa Surya | |
dc.contributor.author | PROBOSUTUIKSNA, Nuno Febrian | |
dc.contributor.author | SUSWATI, Enny | |
dc.date.accessioned | 2021-08-02T03:58:01Z | |
dc.date.available | 2021-08-02T03:58:01Z | |
dc.date.issued | 2020-07-02 | |
dc.identifier.uri | http://repository.unej.ac.id/handle/123456789/104986 | |
dc.description.abstract | The purpose of this study is to know the differences in effectiveness between SAB administration with
combination 5-ARI administration assessed by IPSS evaluation in BPH LUTS patients. Material & Methods: This
observational analytic with a cross-sectional design study had been done to 50 BPH LUTS patients that obtained at Paru
Jember, Bina Sehat Jember, and Bhayangkara Bondowoso Hospital. These samples had got by simple random sampling
method and include in inclusion with exclusion criteria freely. Results:This comparison study between the type of medical
therapy administration and total IPSS decrease, IPSS-voiding decrease, IPSS-storage decrease, IPSS-QoL, and prostate
volume give significancies as follows: p=0.002; p<0.001; p<0.001; p<0.05; p<0.001. Conclusion: There are significant
differences between the type of medical therapy (SAB or 5-ARI combination) and total IPSS decrease, IPSS-voiding
decrease, IPSS-storage decrease, IPSS-QoL, and prostate volume | en_US |
dc.language.iso | en | en_US |
dc.publisher | Indonesian Journal of Urology | en_US |
dc.subject | Benign prostatic hyperplasia (BPH) | en_US |
dc.subject | Lower Urinary Tract Syndrome (LUTS) | en_US |
dc.subject | International Prostatic Symptom Score (IPSS) | en_US |
dc.subject | Selective Alpha Blocker | en_US |
dc.subject | 5-Alpha Reductase Inhibitor | en_US |
dc.title | Differences In The Effectiveness Of Selective Alpha Blocker Therapy Combined With 5-alpha Reductase Inhibitor On Ipss Value Ofbph Luts Patients | en_US |
dc.type | Article | en_US |
dc.identifier.kodeprodi | KODEPRODI2010101#Pendidikan Dokter | |
dc.identifier.nidn | NIDN0022097807 | |
dc.identifier.nidn | NIDN0014027001 | |